Regulate gut microbiota to treat neurodegenerative disorders Grant US-11707493-B2 United States of America 25 Jul 2023
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental… Grant US-11672837-B2 United States of America 13 Jun 2023
Detection and modification of gut microbial population Grant US-11287418-B2 United States of America 29 Mar 2022
Detection and modification of gut microbial population Grant US-11287420-B2 United States of America 29 Mar 2022
Detection and modification of gut microbial population Grant US-11287419-B2 United States of America 29 Mar 2022
Detection and modification of gut microbial population Grant US-11287417-B2 United States of America 29 Mar 2022
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental… Grant US-11202809-B2 United States of America 21 Dec 2021
Diagnosis and treatment of autism spectrum disorder Grant US-11052151-B2 United States of America 06 Jul 2021
Detection and modification of gut microbial population Grant US-11041847-B1 United States of America 22 Jun 2021
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental… Grant US-10675310-B2 United States of America 09 Jun 2020
Diagnosis and treatment of autism spectrum disorder Grant US-10220089-B2 United States of America 05 Mar 2019
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental… Grant US-10124025-B2 United States of America 13 Nov 2018
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental… Grant US-10111914-B2 United States of America 30 Oct 2018
IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk Grant US-9744155-B2 United States of America 29 Aug 2017
Indole lactic acid or a mixture of indole lactic acid and indole-3-propionic acid for… Grant US-9636325-B2 United States of America 02 May 2017
IPA as a therapeutic agent and a biomarker for disease risk for Huntington's disease Grant US-9603837-B2 United States of America 28 Mar 2017
IPA AS A THERAPEUTIC AGENT, AS A PROTECTIVE AGENT, AND AS A BIOMARKER OF DISEASE RISK Application EP-2830617-A4 European Patent Office 20 Jan 2016
METHODS AND USES Application WO-2011010103-A1 World Intellectual Property Organisation (WIPO) 27 Jan 2011